<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10171">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00686231</url>
  </required_header>
  <id_info>
    <org_study_id>56438-31921</org_study_id>
    <nct_id>NCT00686231</nct_id>
  </id_info>
  <brief_title>Radial Artery Dilation Study: The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter</brief_title>
  <official_title>The Effect of Topical Administration of Nitroglycerin and Lidocaine Versus Lidocaine Alone of the Radial Artery Diameter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The radial artery, which is located on the outer side of the forearm, can be used in
      interventional procedures, such as cardiac catheterization, to provide access to the
      arterial blood supply. In order to facilitate successful catheterization of the artery, a
      dilated artery and one free of arterial spasm is desirable. The proposed study will
      randomize twenty three healthy subjects to determine the effect of topical nitroglycerin on
      radial artery vasodilation. In the first phase of the study, which is a dose escalation
      study, each subject will receive either one or two inches of nitroglycerin in a blinded
      manner on one wrist and placebo on the other. Radial artery diameter will be measured with
      ultrasound at regular intervals up to two hours. The subjects will then return at a later
      date at which point they will receive the alternate dose on one wrist and placebo on the
      other. In the second phase of the study, we will randomize the same patients to a mixture of
      topical nitroglycerin and lidocaine or topical lidocaine alone. Measurements of radial
      artery diameter will be performed as in the first study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>To Determine if Topical Nitroglycerin Acts to Vasodilate the Radial Artery.</measure>
    <time_frame>November 2009</time_frame>
    <safety_issue>No</safety_issue>
    <description>Diameter of radial artery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To Determine if Topical Nitroglycerin Dilates the Radial Artery in the Presence of Local Anesthetic Agents Used in Cardiac Catheterization.</measure>
    <time_frame>November 2009</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radial artery diameter</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sorbolene cream</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lidocaine 1 inch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nitro</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 inch / 2 inches of Nitroglycerin applied topically to the wrist</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin</intervention_name>
    <description>1 inch of Nitroglycerin vs 2 inches of Nitroglycerin</description>
    <arm_group_label>Nitro</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Sorbolene cream</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Visit 2 lidocaine 1 inch + best dose Nitro vs Placebo + lidocaine</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Willing and able to give written informed consent and comply with study requirements

          -  Patient who speak English

        Exclusion Criteria:

          -  Presence or history of liver, cardiovascular, rheumatologic, cancer or renal disease.

          -  Current treatment with any vasodilator therapy

          -  Systolic blood pressure of less than 90 mmHg

          -  History of radial artery catheterization within the previous year

          -  Absence of radial artery blood flow in one or both arms

          -  Pregnancy.

          -  Active infection

          -  Staff members of the Cardiac Catheterization Laboratory.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UCSF Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 17, 2013</lastchanged_date>
  <firstreceived_date>May 19, 2008</firstreceived_date>
  <firstreceived_results_date>November 12, 2009</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>To determine if topical nitroglycerin acts to vasodilate the radial artery by a direct local action, or by systemic vasodilation</keyword>
  <keyword>To determine if topical nitroglycerin dilates the radial artery in the presence of local anesthetic agents used in cardiac catheterization</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Nitroglycerin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Sorbolene cream</description>
        </group>
        <group group_id="P2">
          <title>Lidocaine</title>
          <description>Lidocaine 1 inch</description>
        </group>
        <group group_id="P3">
          <title>Nitro</title>
          <description>1 inch / 2 inches of Nitroglycerin applied topically to the wrist</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
                <participants group_id="P3" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo</title>
          <description>Sorbolene cream</description>
        </group>
        <group group_id="B2">
          <title>Lidocaine</title>
          <description>Lidocaine 1 inch</description>
        </group>
        <group group_id="B3">
          <title>Nitro</title>
          <description>1 inch / 2 inches of Nitroglycerin applied topically to the wrist</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="19"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="19"/>
                <measurement group_id="B4" value="57"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="19"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="19"/>
                <measurement group_id="B4" value="57"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="29" spread="4"/>
                <measurement group_id="B2" value="29" spread="4"/>
                <measurement group_id="B3" value="29" spread="4"/>
                <measurement group_id="B4" value="29" spread="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="13"/>
                <measurement group_id="B2" value="13"/>
                <measurement group_id="B3" value="13"/>
                <measurement group_id="B4" value="39"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="6"/>
                <measurement group_id="B3" value="6"/>
                <measurement group_id="B4" value="18"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="19"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="19"/>
                <measurement group_id="B4" value="57"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>To Determine if Topical Nitroglycerin Acts to Vasodilate the Radial Artery.</title>
        <description>Diameter of radial artery</description>
        <time_frame>November 2009</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Sorbolene cream</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine</title>
            <description>Lidocaine 1 inch</description>
          </group>
          <group group_id="O3">
            <title>Nitro</title>
            <description>1 inch / 2 inches of Nitroglycerin applied topically to the wrist</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="19"/>
                  <measurement group_id="O2" value="19"/>
                  <measurement group_id="O3" value="19"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>To Determine if Topical Nitroglycerin Acts to Vasodilate the Radial Artery.</title>
            <description>Diameter of radial artery</description>
            <units>mm</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.2" spread="0.7"/>
                  <measurement group_id="O2" value="0.1" spread="0.3"/>
                  <measurement group_id="O3" value="0.7" spread="0.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>To Determine if Topical Nitroglycerin Dilates the Radial Artery in the Presence of Local Anesthetic Agents Used in Cardiac Catheterization.</title>
        <description>Radial artery diameter</description>
        <time_frame>November 2009</time_frame>
        <safety_issue>No</safety_issue>
        <posting_date>11/2009</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Placebo</title>
          <description>Sorbolene cream</description>
        </group>
        <group group_id="E2">
          <title>Lidocaine</title>
          <description>Lidocaine 1 inch</description>
        </group>
        <group group_id="E3">
          <title>Nitro</title>
          <description>1 inch / 2 inches of Nitroglycerin applied topically to the wrist</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>a</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Andrew Boyle</name_or_title>
      <organization>UCSF</organization>
      <phone>415-514-0827</phone>
      <email>aboyle@medicine.ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
